MedTrace Logo

European Transplant Registry of Senior Renal Transplant Recipients on Advagraf

NCT02558452 · Status: NOT_YET_RECRUITING · Type: OBSERVATIONAL · Enrollment: 1000

Last updated 2016-08-12

No results posted yet for this study

Summary

SENIOR transplant Registry European transplant registry of senior renal transplant recipients (above the age of 65 years) receiving initial immunosuppression with tacrolimus once daily, mycophenolate and steroids to investigate long term outcomes on an observational basis.

Conditions

  • Graft Failure
  • Death
  • Acute Rejection of Renal Transplant
  • Infections
  • Bone Disease
  • Post Transplant Diabetes Mellitus
  • Quality of Life
  • HLA Antibody Production
  • Cardiovascular Risk Factors
  • Non-HLA Antibody Production

Interventions

DRUG

Tacrolimus once daily (Advagraf)

Antibody induction by antithymocyte Globulin (ATG) or Basiliximab possible but not mandatory

Sponsors & Collaborators

  • Dr. med. univ. L. J. Lehner

    collaborator UNKNOWN

  • Charite University, Berlin, Germany

    collaborator OTHER

  • ERA-EDTA

    collaborator UNKNOWN

  • DESCARTES Working Group On Transplantation

    collaborator OTHER

  • European Kidney Transplant Association (EKITA)

    collaborator OTHER

  • Klemens Budde

    lead OTHER

Principal Investigators

  • Lukas J Lehner, MD · Charite University, Berlin, Germany

Eligibility

Min Age
65 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2016-12-31
Primary Completion
2027-01-31
Completion
2028-01-31

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02558452 on ClinicalTrials.gov